Clinical Trials Directory

Trials / Unknown

UnknownNCT02090062

Difference in H. Pylori Infection Rate of EGC Patients Before and After Endoscopic Resection

Status
Unknown
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Shanghai Jiao Tong University School of Medicine · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Parts of patients are diagnosed as H. pylori -negative before ER, whereas the specimens become H. pylori-positive after ER, which may have a role in the recurrence of EGC. Our study aims to determine the difference in H. pylori infection rate of EGC patients before and after ER , and discuss the causes leading to the difference, which can provide references for improving the diagnostic accuracy of H. pylori infection and reducing EGC's recurrence rate.

Detailed description

Gastric cancer is the fourth most commonly diagnosed cancer in the world and the second leading cause of cancer-related deaths. Nowadays, endoscopic resection(ER) is widely accepted as the primary treatment for early gastric cancer (EGC) without lymph node metastasis,which includes endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD).However, recurrence rate after endoscopic resection for EGC still achieves 6.7%-14%. However, there is no comparative analysis about H. pylori infection rate before and after ER yet.

Conditions

Timeline

Start date
2014-03-01
Primary completion
2015-09-01
Completion
2015-09-01
First posted
2014-03-18
Last updated
2014-03-19

Source: ClinicalTrials.gov record NCT02090062. Inclusion in this directory is not an endorsement.